1. Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial. Issue 10 (October 2022) Authors: Herman, Gary A; O'Brien, Meagan P; Forleo-Neto, Eduardo; Sarkar, Neena; Isa, Flonza; Hou, Peijie; Chan, Kuo-Chen; Bar, Katharine J; Barnabas, Ruanne V; Barouch, Dan H; Cohen, Myron S; Hurt, Christopher B; Burwen, Dale R; Marovich, Mary A; Musser, Bret J; Davis, John D; Turner, Kenneth C; Mahmood,... Journal: Lancet infectious diseases Issue: Volume 22:Issue 10(2022) Page Start: 1444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Model‐informed drug repurposing: A pharmacometric approach to novel pathogen preparedness, response and retrospection. Issue 9 (23rd February 2021) Authors: Dodds, Michael; Xiong, Yuan; Mouksassi, Samer; Kirkpatrick, Carl M.; Hui, Katrina; Doyle, Eileen; Patel, Kashyap; Cox, Eugène; Wesche, David; Brown, Fran; Rayner, Craig R. Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 9(2021) Page Start: 3388 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗